Increased 2026 cash spend guidance to $85 million - $95 million due to accelerated hiring of medical science liaisons and expanded commercial infrastructure.
Palvella Therapeutics (NASDAQ:PVLA) held its second-quarter earnings conference call on Tuesday. Below is the complete ...
StockStory.org on MSN
Martin Marietta Materials’s (NYSE:MLM) Q2 CY2026 sales beat estimates, guides for strong full-year sales
Construction materials supplier Martin Marietta Materials (NYSE:MLM) announced in Q2 CY2026, with sales up 21.1% year on year ...
StockStory.org on MSN
MLM Q2 deep dive: Acquisitions and mix weigh on margins, guidance raised amid cost discipline
Construction materials supplier Martin Marietta Materials (NYSE:MLM) reported in Q2 CY2026, with sales up 21.1% year on year to $1.95 billion. The company’s full-year revenue guidance of $7.3 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results